74772-78-4,
5-(4-Hydroxybenzyl)thiazolidine-2,4-dione,
5-(4-Hydroxybenzyl)-2,4-thiazolidinedione,
5-(4-HYDROXYBENZYL)-1,3-THIAZOLIDINE-2,4-DIONE,
U-90441,
2,4-dioxo-5-[(p-hydroxyphenyl)-methyl]thiazolidine,
5-[(4-Hydroxyphenyl)methyl]-2,4-thiazolidinedione,
2,4-Thiazolidinedione, 5-[(4-hydroxyphenyl)methyl]-,
Glitazone,
5-(4-Hydroxybenzyl)thiazolidin-2,4-dione,
ACMC-1BF0J,
Pioglitazone Metabolite M1,
SCHEMBL623021,
SCHEMBL18174924,
CTK5E0483,
NKOHRVBBQISBSB-UHFFFAOYSA-N,
ZX-AT015682,
ANW-36524,
CH-087,
KM1640,
MFCD00754499,
AKOS015903570,
OR60257,
TRA0100262,
AK-82429,
CS-11094,
SY005289,
AB0063927,
AX8174283,
TC-125269,
5-(4-hydroxy-benzyl)thiazolidine-2,4-dione,
5-(4-hydroxybenzyl)-thiazolidine-2,4-dione,
CS-0067330,
FT-0669424,
ST24044202,
Z2452,
MFCD00754499 (95+%),
772H784,
AN-584/43510715,
U 90441,
2,4-Thiazolidinedione,5-[(4-hydroxyphenyl)methyl]-,
I14-17505,
5-(4-hydroxybenzyl)-2,4-thiazolidinedione, AldrichCPR,
D0S2BV,
UNII-M8U25244KP,
CHEMBL1061,
5- -2,4-thiazolidinedione,
C10H9NO3S,
M8U25244KP,
CID10198397,
H1299,
5-[(4-hydroxyphenyl)methyl]-1,3-thiazolidine-2,4-dione,
2295-31-0,
6482-98-0,